Deals worth $100 billion on Monday put the Street on pace for a year rivaling the dot-com bubble era and the private equity surge just before the financial crisis.» Read More
*Wide variety of e-cigs a problem for researchers. *Tobacco firms join e-cig companies in sponsoring research. LONDON, Jan 22- From Apple Pie to Bubbly Bubble Gum, Irish Car Bomb or Martian bar- from Mars!
SEATTLE, Jan 21- Washington state could become the only U.S. state to raise its legal age for smoking tobacco to 21 from 18 under a measure proposed on Wednesday by its top law enforcement official. Cigarette smoking is the leading cause of preventable death in the United States, accounting for more than 480,000 deaths annually, or one of every five deaths overall,...
While precise figures are not available, the American Red Cross and its U.S. affiliates have received at least $12 million from tobacco companies such as Altria Group, Reynolds American and Philip Morris International since 2001, according to Red Cross tax records and tobacco company press releases and annual reports. An American Red Cross spokeswoman,...
Nov 24- Canadian buyout firm Onex Corp said it would buy Swiss packaging group SIG Combibloc Group AG for up to 3.57 billion euros. The deal is expected to close in the first quarter of 2015, subject to regulatory approvals, Onex said. Reuters reported earlier this month that Onex, Canada's largest listed private equity firm, was leading the bidding for SIG...
LONDON, Nov 4- Imperial Tobacco Group said it would raise its dividend by at least 10 percent in the next year, signalling confidence that cost cuts will help it to cope with weak consumer spending and higher taxes that weighed on its annual profit. The company also recently floated a portion of its logistics business, Logista, on the Spanish stock exchange, raising...
WASHINGTON, Oct 29- Cigarette maker Reynolds American's proposal to buy smaller rival Lorillard Inc presents antitrust regulators with a conundrum: Their mandate is to prevent higher prices because of mergers, but U.S. public policy aims to make cigarettes more expensive to discourage smoking. Reynolds, the No. 2 U.S. cigarette maker, said in July it would buy No. 3...
President and chief commercial officer, R.J. Reynolds Tobacco
LONDON/ NEW YORK, Sept 12- As electronic cigarettes flew off shelves on both sides of the Atlantic in recent years, investors flocked to a business some hope will be the future for tobacco.
Sept 3- Lorillard Inc said two of its e-cigarette subsidiaries sued Zippo Manufacturing Co in the United Kingdom to protect itself from Zippo's claims of trademark infringement regarding the blu brand of e-cigarettes.
The success is therefore a "monumental achievement," virologist Thomas Geisbert of the University of Texas Medical Branch wrote in a commentary on the paper, published online in Nature.
CHICAGO, Aug 25- Electronic cigarettes may be more tempting to non-smoking youths than conventional cigarettes, and once young people have tried e-cigarettes they are more inclined to give regular cigarettes a try, U.S. researchers said on Monday.
Aug 18- A German court has ordered a subsidiary of U.S. tobacco giant Lorillard Inc to stop selling the popular blu e-cigarettes in that country, citing trademark confusion with lighter and fuel products sold by Zippo Manufacturing Co..
LOS ANGELES, Aug 17- Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies.
All three U.S. laboratories established to fight major public health threats say they are standing by to scale up a treatment for Ebola.
NEW YORK/ WASHINGTON, Aug 9- All three U.S. facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.
The M&A wave could be a harbinger of a booming economy...or a collection of last-minute attempts to beat higher debt rates. NYT reports.
NEW YORK, Aug 6- Drugmakers' use of the tobacco plant as a fast and cheap way to produce novel biotechnology treatments is gaining global attention because of its role in an experimental Ebola therapy.
Companies across industry groups—from food to technology to health care—are raising costs for the consumer.
Susan Cameron is confident regulators will allow the tobacco giant to acquire Lorillard for $24.7 billion.
A cult following is likely to grow as "vaping" becomes more fashionable and more stores, such as Walmart, carry the battery-powered metal tubes in a wide range of colors.